Flagship explainer
What drives ANAPTYSBIO, INC.’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| −$13.2M | FY2025 |
| |
| Income before tax | −$13.1M | FY2025 |
|
| Operating income | $47.9M | FY2025 |
|
| $235M | FY2025 |
| |
| Ending assets | $364M | FY2025 |
|
| Beginning assets | $484M | FY2024 |
|
| $37.2M | FY2025 |
| |
| $70.9M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001193125-26-088290
- SEC filingFiling detailsAccession 0001193125-26-187044